Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole versus mexiletine in adults with non-dystrophic myotonia
2014-002627-10Phase 2Completed
- Sponsor
- Carlo Besta Neurological Institute
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in non-dystrophic myotonia (NDM) comparing Riluzole with Mexiletine (2 arms). Primary endpoint: Patient-reported stiffness on the Interactive Web Response diary. Started Nov 2020; status: completed.
02
Drugs
riluzolemexiletine
03
Conditions
non-dystrophic myotonia (NDM)
Beyond the preview
Go deeper on 2014-002627-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002627-10.